Semax 30 MG

Semax is a synthetic heptapeptide with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, derived from the fragment 4-10 of adrenocorticotropic hormone (ACTH). It is designed for enhanced neuroprotective, nootropic, and neurotrophic effects, primarily targeting the central nervous system.

Pharmacokinetics and mechanism of action highlights for Semax:

• Semax rapidly elevates brain-derived neurotrophic factor (BDNF) expression and TrkB receptor levels in the hippocampus and other key brain regions, promoting neuronal survival, growth, and synaptic plasticity.
• It modulates multiple neurotransmitter systems including dopaminergic, serotonergic, and noradrenergic pathways, contributing to improved cognitive function, mood regulation, and stress resilience.
• Semax demonstrates antioxidant properties and inhibits amyloid beta fibril formation, especially in the presence of copper ions, which may contribute to neuroprotection in Alzheimer’s models.
• It interacts with melanocortin receptors and may inhibit enkephalinase enzymes, though the full mechanism remains under study.
• The peptide shows good stability as a lyophilized powder and exhibits resistance to enzymatic degradation, enabling sustained biological effects after administration.
Semax is extensively researched for applications in cognitive enhancement, neuroprotection, stroke recovery, depression, and neurodegenerative diseases. It is supplied as a lyophilized powder for research use only (RUO) and is not approved for clinical or therapeutic use outside regulated settings.

Product details:

• Amino Acid Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Molecular Weight: Approximately 814 Da
• Appearance: White to off-white lyophilized powder
• Known for: Neurotrophic, nootropic, antioxidant properties

Semax’s multifunctional neuroprotective actions and stability make it a valuable tool in neuroscience research and potential therapeutic development for CNS disorders.